Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. CureVac N.V.
  6. News
  7. Summary
    CVAC   NL0015436031

CUREVAC N.V.

(CVAC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about CUREVAC N.V.
09/15Correction to CureVac 2nd Update Article on Sept. 14
DJ
09/15CureVac Cancels mRNA Contracts For COVID-19 Jab
MT
09/14CUREVAC N : Contracts with manufacturing partners WACKER and Celonic terminated;..
PU
09/14CUREVAC N : Terminates Two Manufacturing Contracts Amid Streamlining of European..
MT
09/14CUREVAC N : Terminates 2 Manufacturing Contracts Amid Streamlining of European m..
MT
09/14CUREVAC N : Streamlines European Network for mRNA Product Manufacturing
PU
09/14CUREVAC N : Streamlines European Network for mRNA Product Manufacturing
EQ
09/14PRESS RELEASE : CureVac Streamlines European Network for mRNA Product Manufactur..
DJ
09/14CureVac Streamlines European Network for mRNA Product Manufacturing
CI
09/14CureVac Shares Fall Premarket on Termination of Vaccine Contracts With Wacker..
DJ
09/14CureVac Terminates Covid Vaccine Manufacturing Contract With Wacker Chemie, C..
DJ
08/31Health Care Stocks Add to Early Slide
MT
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet ..
PU
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet
PU
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet
EQ
More most relevant news
All news about CUREVAC N.V.
09/15Correction to CureVac 2nd Update Article on Sept. 14
DJ
09/15CureVac Cancels mRNA Contracts For COVID-19 Jab
MT
09/14CUREVAC N : Contracts with manufacturing partners WACKER and Celonic terminated;..
PU
09/14APPLE : U.S. stocks close lower on worries over recovery, corporate tax hikes
RE
09/14INTUIT : Wall Street dips as choppy recovery, looming tax hikes weigh on sentime..
RE
09/14CUREVAC N : Terminates Two Manufacturing Contracts Amid Streamlining of European..
MT
09/14Health Care Stocks Rally Early Tuesday
MT
09/14CUREVAC N : Terminates 2 Manufacturing Contracts Amid Streamlining of European m..
MT
09/14CUREVAC N : Streamlines European Network for mRNA Product Manufacturing
PU
09/14CUREVAC N : Streamlines European Network for mRNA Product Manufacturing
EQ
More news
News in other languages on CUREVAC N.V.
09/15Börse Stuttgart-News: Euwax Trends
09/14WALL STREET STOCK EXCHANGE : Wall Street finit en baisse, craintes sur la croiss..
09/14Curevac unter Druck - Nachfrage nach Impfstoff geringer
09/14CureVac met fin à deux contrats de fabrication dans le cadre de la rationalis..
09/14Dow Jones Industrial Average : Borsa Usa in calo, incertezza su tassazione co..
09/14Les actions du secteur de la santé en hausse mardi matin
09/14CureVac gibt Produktionspartnerschaften für Covid-19-Impfstoff auf
09/14Curevac kündigt Wacker-Vertrag zur Produktion von mRNA-Impfstoff
09/14CureVac verschlankt europäisches -2-
09/14CureVac verschlankt europäisches Netzwerk zur mRNA-Produktherstellung
More news
Analyst Recommendations on CUREVAC N.V.
07/01CUREVAC : Berenberg reaffirms its Buy rating
MD
06/17CUREVAC N : BofA Securities Downgrades CureVac to Neutral From Buy; Price Target..
MT
04/26CUREVAC N : Guggenheim Initiates CureVac at Buy
MT
02/18CUREVAC : Berenberg reaffirms its Buy rating
MD
2020CUREVAC N : Credit Suisse Downgrades CureVac to Underperform from Neutral, Adjus..
MT
More recommendations
Press releases
09/14CUREVAC N : Contracts with manufacturing partners WACKER and Celonic terminated;..
PU
09/14CUREVAC N : Streamlines European Network for mRNA Product Manufacturing
PU
09/14CUREVAC N : Streamlines European Network for mRNA Product Manufacturing
EQ
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet ..
PU
08/31CUREVAC N : CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet
PU
More press releases
Upcoming event on CUREVAC N.V.